Abstract
Bilateral infusions of d-amphetamine into the rat ventral-lateral striatum (VLS) were previously shown to cause a robust behavioral activation that was correlated temporally with a net increase in firing of substantia nigra pars reticulata (SNpr) neurons, a response opposite predictions of the basal ganglia model. The current studies assessed the individual and cooperative contributions of striatal D1 and D2 dopamine receptors to these responses. Bilateral infusions into VLS of the D1/D2 agonist apomorphine (10 μg/μl/side) caused intense oral movements and sniffing, and an overall increase in SNpr cell firing to 133% of basal rates, similar to effects ofd-amphetamine. However, when striatal D2receptors were stimulated selectively by infusions of quinpirole (30 μg/μl/side) + the D1 antagonistR-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390; 10 μg/μl/side), no behavioral response and only modest and variable changes in SNpr cell firing were observed. Selective stimulation of striatal D1 receptors by (±) 6-chloro-APB hydrobromide (SKF 82958; 10 μg/μl/side) + the D2 antagonistcis-N-(1-benzyl-2-methyl-pyrrolidin-3-yl)-5-chloro-2-methoxy-4-methyl-aminobenzamide (YM 09151-2; 2 μg/μl/side) caused a weak but sustained increase in oral movements and modestly increased SNpr cell firing, but neither response was of the magnitude observed with apomorphine. When the two agonists were infused concurrently, however, robust oral movements and sniffing again occurred over the same time period that a majority of SNpr cells exhibited marked, sometimes extreme and fluctuating, changes in firing (net increase, 117% of basal rates). These data confirm that concurrent striatal D1/D2 receptor stimulation elicits a strong motor activation that is correlated temporally with a net excitation rather than inhibition of SNpr firing, and reveal that D1and D2 receptors interact synergistically within the striatum to stimulate both forms of output.
Footnotes
-
These studies were supported by National Institutes of Neurological Disorders and Stroke Grant NS 23541 to B.L.W. The behavioral studies reported in this article served as the Senior Honors Thesis of Heather Finlay in the Behavioral Neuroscience program at Northeastern University. A preliminary report of this work was published in 1997 in Abstr Soc Neurosci23:190.
- Abbreviations:
- SNpr
- substantia nigra pars reticulata
- VLS
- ventral-lateral striatum
- AMPT
- α-methyl-p-tyrosine
- ANOVA
- analysis of variance
- SKF 82958 ((±)6-chloro-APB hydrobromide)
- (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzapenine hydrobromide
- YM 09151-2
- cis-N-(1-benzyl-2-methyl-pyrrolidin-3-yl)-5-chloro-2-methoxy-4-methyl-aminobenzamide
- SCH 23390
- R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- CY 208243
- (−)-4,6,6a,7,8,12b-hexahydro-7-methyl-indolo[4,3-ab]-phenanthridine
- Received September 27, 2001.
- Accepted December 5, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|